| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.95▼ | 2.83▲ | 2.78▲ | 2.74▲ | 2.56▲ |
| MA10 | 2.88▲ | 2.74▲ | 2.72▲ | 2.66▲ | 2.93▼ |
| MA20 | 2.80▲ | 2.72▲ | 2.73▲ | 2.57▲ | 4.00▼ |
| MA50 | 2.73▲ | 2.73▲ | 2.67▲ | 3.15▼ | N/A |
| MA100 | 2.75▲ | 2.65▲ | 2.55▲ | 4.25▼ | N/A |
| MA200 | 2.66▲ | 2.51▲ | 2.77▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | 0.029▲ | 0.017▲ | 0.090▲ | N/A |
| RSI | 65.326▲ | 72.298▲ | 66.918▲ | 52.145▲ | 29.079▼ |
| STOCH | 83.790▲ | 90.238▲ | 65.879 | 65.665 | 27.764 |
| WILL %R | -26.667 | -18.391▲ | -18.391▲ | -14.424▲ | -72.155 |
| CCI | 84.586 | 174.069▲ | 226.522▲ | 128.268▲ | -57.548 |
|
Wednesday, February 11, 2026 02:00 AM
Key anticipated benefits of an orphan drug designation include 7 years of U.S. market exclusivity, up to 25% of tax credits on clinical trials conducted in the USA, exemption from FDA Prescription ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/02/26 | 2.64 | 3.05 | 2.54 | 2.90 | 248,400 |
| 20/02/26 | 2.73 | 2.798 | 2.61 | 2.63 | 56,300 |
| 19/02/26 | 2.82 | 2.82 | 2.66 | 2.75 | 55,700 |
| 18/02/26 | 2.58 | 3.00 | 2.58 | 2.81 | 242,200 |
| 17/02/26 | 2.51 | 2.70 | 2.51 | 2.63 | 71,142 |
| 13/02/26 | 2.57 | 2.75 | 2.56 | 2.59 | 123,518 |
| 12/02/26 | 2.55 | 2.64 | 2.52 | 2.61 | 130,618 |
| 11/02/26 | 2.53 | 2.605 | 2.32 | 2.56 | 141,490 |
| 10/02/26 | 2.54 | 2.7131 | 2.50 | 2.57 | 148,801 |
| 09/02/26 | 2.81 | 2.84 | 2.54 | 2.57 | 228,324 |
|
|
||||
|
|
||||
|
|